파마리서치
214450KOSDAQ의료용품 및 기타 의약 관련제품 제조업50.2 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Parmaresearch is a biopharmaceutical company specializing in regenerative medicine, leveraging PDRN/PN technology to develop and sell pharmaceuticals, medical devices, and cosmetics. Established in 2013 with a GMP-certified factory in Gangneung and expanded with a second plant in 2019, the company's key products include Regenix, Rejuran, and Conjuuran. It plans to expand into Asian, European, and North American markets, while its subsidiary also operates a botulinum toxin business.
Number of Employees
526people
Average Salary
68.5M KRW
Score Calculation Basis
Detailed Financial Score
In line with industry avg
3.0x industry avg (risky)
Well below industry avg
4.2x industry avg (risky)
Avg ▲43.7% (2-year basis)
Avg ▲53.4% (2-year basis)
Avg ROE 20.6% (improving, 3yr)
Detailed News Sentiment
- PositivePDRN, 해양조류서도 뽑는다…파마리서치에 도전장 낸 회사
파마리서치의 새로운 탈모 샴푸 '그래비티'가 제주 해양 미세조류에서 추출한 PDRN을 활용해 출시되며, 시장 경쟁력 강화와 매출 증대 기대.
- PositivePDRN이 두피에 착! 탈모까지 막는다
파마리서치의 새로운 PDRN 탈모샴푸가 두피 부착력과 탈모 예방 효과를 향상시켜 시장 경쟁력을 강화할 것으로 기대된다.
- Positive피부 넘어 두피까지…헤어케어 시장으로 번진 PDRN 열풍 [트렌드]
PDRN 기반 신제품 출시로 파마리서치의 헤어케어 시장 확장 기대
Detailed Momentum
Near 52w low (0%, downtrend)
1m -16.99% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral기업설명회(IR)개최2026-06-09
- Neutral분기보고서 (2026.03)2026-05-15
